Form 4: ICU Medical Director Kolleen Kennedy Reports Stock Transactions
SEC Form 4 Filing
Director Kolleen Kennedy of ICU Medical Inc. reports acquisition and disposal of common stock and derivative securities.
Summary
- On May 13, 2025, Kolleen Kennedy, a director at ICU Medical Inc., reported transactions involving the company's common stock and derivative securities.
- Kennedy acquired 1,723 shares of common stock and disposed of 3,285 shares.
- She also acquired 1,254 derivative securities (Restricted Stock Units) exercisable on May 13, 2026, and disposed of 1,723 derivative securities.
- The transactions were related to the vesting and disposal of Restricted Stock Units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company leadership.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a director.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of earliest transaction: acquisition and disposal of common stock and derivative securities. |
| 05/13/2026 | Date derivative securities (Restricted Stock Units) become exercisable. |
| 05/15/2025 | Expiration date of derivative securities. |
Keywords
ICU Medical, Director, Stock Transactions, Form 4, Beneficial Ownership, Restricted Stock Units, ICUI, Kennedy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.